ARCHIVES

OMB Revisions Would Kill 16 Center core Grants, Ban New Ones, Slash Noncompeting Funds 10 Percent

This article is from The Cancer Letter archive.

Vol. 09 No. 15 | April 15, 1983

Download PDF Visit The Full Archive

Related Articles

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992

NCAB Approves Plan for National Black Leadership Initiative

October 16, 1987

Senate, House Budget Plans Likely To Result In Modest Funding Increases For NIH, NCI

May 11, 1990

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013